Main text area

• A variety of products are in development, with the specialized technologies and experiences in vaccine products.
• Euvichol^® was launched as the first product of EuBiologics in the end of 2015, and CRM₁₉₇ the immunological transferring protein, was launched in 2016. A new product will be launched in around 2020.

• Please contact the research institute to express any intentions of collaboration or joint research with EuBiologics.
  
  Q&A to R&D Center